Silphium Asset Management Ltd Reduces Stake in HealthEquity, Inc. $HQY

Silphium Asset Management Ltd reduced its position in HealthEquity, Inc. (NASDAQ:HQY) by 44.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,478 shares of the company’s stock after selling 10,922 shares during the period. Silphium Asset Management Ltd’s holdings in HealthEquity were worth $1,235,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in HealthEquity by 4.7% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 25,602 shares of the company’s stock valued at $2,345,000 after purchasing an additional 1,146 shares in the last quarter. Merit Financial Group LLC increased its stake in HealthEquity by 35.3% in the 4th quarter. Merit Financial Group LLC now owns 2,857 shares of the company’s stock valued at $262,000 after purchasing an additional 745 shares in the last quarter. CWM LLC increased its stake in HealthEquity by 15.2% in the 4th quarter. CWM LLC now owns 7,405 shares of the company’s stock valued at $678,000 after purchasing an additional 979 shares in the last quarter. Farther Finance Advisors LLC increased its stake in HealthEquity by 117.1% in the 4th quarter. Farther Finance Advisors LLC now owns 851 shares of the company’s stock valued at $78,000 after purchasing an additional 459 shares in the last quarter. Finally, Tectonic Advisors LLC increased its stake in HealthEquity by 0.8% in the 4th quarter. Tectonic Advisors LLC now owns 77,525 shares of the company’s stock valued at $7,102,000 after purchasing an additional 594 shares in the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the company. BTIG Research dropped their price objective on HealthEquity from $130.00 to $110.00 and set a “buy” rating for the company in a research note on Tuesday, February 17th. JPMorgan Chase & Co. dropped their price objective on HealthEquity from $129.00 to $123.00 and set an “overweight” rating for the company in a research note on Wednesday, March 18th. Barclays dropped their price objective on HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a research note on Wednesday, February 18th. Jefferies Financial Group set a $108.00 price objective on HealthEquity in a research note on Thursday, February 19th. Finally, BMO Capital Markets upgraded HealthEquity from a “market perform” rating to an “outperform” rating and increased their target price for the company from $85.00 to $105.00 in a report on Thursday, April 9th. One investment analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $111.79.

HealthEquity Price Performance

Shares of NASDAQ:HQY opened at $86.04 on Monday. The business’s fifty day moving average price is $79.79 and its two-hundred day moving average price is $88.49. The stock has a market cap of $7.27 billion, a PE ratio of 34.98, a price-to-earnings-growth ratio of 1.56 and a beta of 0.26. The company has a debt-to-equity ratio of 0.45, a quick ratio of 3.27 and a current ratio of 3.27. HealthEquity, Inc. has a one year low of $72.76 and a one year high of $116.65.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, March 17th. The company reported $0.95 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.05. The firm had revenue of $334.59 million for the quarter, compared to analysts’ expectations of $332.48 million. HealthEquity had a return on equity of 13.86% and a net margin of 16.39%.The business’s revenue for the quarter was up 7.3% on a year-over-year basis. On average, analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.